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The aim of this study was to investigate the occurrence of multidrug-resistant, extended
spectrum beta-lactamase (ESBL) producing Salmonella spp. isolated from conveyor belts of
broiler cutting rooms in Brazilian broiler processing plants. Ninety-eight strains of Salmonella
spp.  were analyzed. Multidrug resistance was determined by the disk diffusion test and
the susceptibility of the isolated bacteria was evaluated against 18 antimicrobials from
seven  different classes. The double disk diffusion test was used to evaluate ESBL produc-
tion. Of the 98 strains tested, 84 were multidrug resistant. The highest rates of resistance
were  against nalidixic acid (95%), tetracycline (91%), and the beta-lactams: ampicillin and
cefachlor (45%), followed by streptomycin and gentamicin with 19% and 15% of strain resis-
tance, respectively. By contrast, 97% of the strains were sensitive to chloramphenicol. 45%
of  the strains were positive for the presence of ESBL activity. In this study, high rates of
multidrug resistance and ESBL production were observed in Salmonella spp.©  2015 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).∗ Corresponding author.
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Introduction
Salmonella spp. is one of the main agents responsible for sev-
eral infections, e.g., food borne gastroenteritis. Most of these
infections cause self-limiting diarrhea and do not require
antimicrobial treatment. However, in certain cases, such as
when the bacterium is spread via blood stream leading to
complications such as meningitis, antibiotic therapy is nec-
essary. Such complications are most commonly observed in
children and elderly and immune compromised patients. Flu-
oroquinolones and cephalosporins are the drugs of ﬁrst-choice
in such cases.1
Food of animal origin, especially poultry derived items,
are the main sources of infection by Salmonella spp.2 Given
the importance to Salmonella spp. as causative agents in food
borne diseases, reduction of its contamination on broiler car-
casses is of extremely high priority for industry as well as
regulatory agencies.3 The occurrence of Salmonella spp. on the
broiler carcasses might be a result of contamination either
at the farm or cross-contamination within the processing
plant.4 Cross-contamination can be attributed partly to resid-
ual bacteria remaining on surfaces and equipment after
sanitization.5
Studies on Salmonella spp. are usually focused on ana-
lyzing resistance of the bacterium to antimicrobials such
as ﬂuoroquinolones; but, in the last decade or so, bac-
terial production of large spectrum beta-lactamases has
also been evaluated.6,7 In Enterobacteriaceae, resistance to
cephalosporins is generally attributed to the production of
large spectrum beta-lactamases such as ESBL (extended spec-
trum beta-lactamase) and AmpC beta-lactamase.8 ESBL is the
term used for any beta-lactamase that is acquired and not
intrinsic to a species. Such lactamases quickly hydrolyze and
confer resistance against oxyimino-cephalosporins. Mutant
beta-lactamases that have similar activity are also referred to
as ESBLs.9,10
Extensive studies have been undertaken to analyze ESBL
production by Klebsiella spp., Enterobacter spp., and Escherichia
coli isolated from human clinical samples. These studies
are prompted by the lack of therapeutic success against
these microorganisms, which includes, but not restricted to,
cephalosporins. Treatment is rendered unsuccessful by the
acquisition of resistance genes that reside on mobile genetic
elements. For example, plasmids that transmit resistance
genes for cephalosporins are frequently found to carry resis-
tance to other antibiotics, such as ﬂuoroquinolones.11 Some
authors have also reported ESBLs in microorganisms isolated
from food products.12–14 According to Blanc et al. (2006), these
ﬁndings are more  recent in the case of E. coli and Salmonella
spp. as compared to Klebsiella spp. and Enterobacter spp. ESBL
production by Salmonella spp. isolated from animals has also
been reported15,16; although, the reports on ESBL from animal
origin are less frequent.17,18
Due to the public health risk of cross-contamination, it
is important to have sufﬁcient information on the occur-
rence of pathogens, e.g., Salmonella spp., in the cutting rooms
for broiler processing and slaughtering facilities. It is espe-
cially important to have knowledge of the behavior of these
strains against antimicrobials. Therefore, the objective of b i o l o g y 4 7 (2 0 1 6) 191–195
this study was to determine the occurrence of multidrug
resistant in ESBL-producing Salmonella spp. isolated from
conveyor belts in the cutting rooms of broiler processing
plants.
Materials  and  methods
Isolation  and  identiﬁcation  of  Salmonella  spp.
Strains of Salmonella spp. were obtained from the cutting
rooms of four different Brazilian broiler processing and export-
ing plants having a slaughtering capacity in excess of 160,000
broilers/day. For the isolation of Salmonella spp. from the sur-
face of the conveyor belts, the sponges (Nasco Whirl-PakTM),
pre-moistened with 10 mL  of 0.1% saline peptone water, were
utilized on a 400 cm2 area. Salmonella spp. detection was car-
ried out according to the Food and Drug Administration (FDA –
USA) methodology as published in the Bacteriological Analyt-
ical Manual.19 Subsequent to these tests, isolates of Salmonella
spp. were conﬁrmed by genus identiﬁcation using polymerase
chain reaction (PCR) for the sifB gene as per the protocol
described by Almeida et al.20
Antimicrobial  susceptibility  test
The susceptibility to antimicrobials was determined using
the agar diffusion test as per the documents M31-A321
and M100-S2322 of the Clinical and Laboratory Standards
Institute. Eighteen antimicrobial agents from seven dif-
ferent classes were tested: (1) Beta-lactams, divided into
3 subclasses: (a) Penicillins: ampicillin (AMP; 10 g), (b)
Cephalosporins: cefachlor (CFC; 30 g) and ceftiofur (CTF;
30 g), and (c) Carbapenems: meropenem (MER;10 g) and
imipenem (IPM; 10 g); (2) Aminoglycosides: streptomycin
(EST; 10 g), tobramycin (TOB; 10 g), gentamycin (GEN;
10 g), amikacin (AMI; 30 g) and neomycin (NEO; 30 g);
(3) Quinolones: enroﬂoxacin (ENO; 5 g), nalidixic acid (NAL;
30 g), and ciproﬂoxacin (CIP; 5 g); (4) Sulfamethoxazole and
Trimethoprim: sulfamethoxazole/trimethoprim (SUT; 25 g);
(5) Tetracyclines: tetracycline (TET; 30 g); (6) Phenicols: chlor-
amphenicol (CLO; 30 g) and ﬂorfenicol (FLF; 30 g) and (7)
Polymyxins: polymyxin B (POL, 300 UI). Strains were consid-
ered multidrug resistant if they were resistant to at least three
classes of antimicrobials (at least one antimicrobial of each
class).23 The quality control test was based on E. coli ATCC
25922.
ESBL  production
ESBL production was analyzed by the double disk diffusion
test.24 The central disk was having amoxicillin plus clavulanic
acid (AMX/AC; 20/10 g). Four other disks were placed within
a 20 mm radius of the ﬁrst one: ceftazidime (CAZ; 30 g), cef-
triaxone (CRO; 30 g), cefepime (CPM, 30 g) and aztreonam
(ATM; 30 g).25 Samples were considered positive for ESBL
when the inhibition zone around any cephalosporin increased
toward the central disk with AMX/AC, and when the inhibition
zone around at least one of the cephalosporins was smaller
than 19 mm.26
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esults
ut of the 98 strains evaluated (26, 23, 19, and 30 from each of
he four cutting rooms, respectively), three were sensitive to all
ntimicrobials tested, four were resistant to one class, seven
ere resistant to two classes, and 84 (86%) were considered
ultidrug resistant.
Fig. 1 shows the resistance proﬁles of the multidrug resis-
ant strains arranged according to the room of origin, and
he corresponding percentage proﬁles in each room. ESBL
ctivity was detected in 45% of the strains. From the strains
ositive for ESBL production, the most frequent resistance pro-
le was against beta-lactams, quinolones, and tetracyclines
38/44); the ESBL-negative strains were resistant to aminogly-
osides, quinolones, and tetracyclines (36/54). The results for
almonella spp. antimicrobial susceptibility test are presented
n Fig. 2.
The strains, sensitive to all antimicrobials (3/98), originated
rom Room 3 and represented 16% (3/19) of the total num-
er of strains isolated from this room. The same percentage
f resistance was observed for only one or two antimicrobial
lasses and 52% (10/19) strains were multidrug resistant. How-
ver, in Rooms 1, 2, and 4, 100% (26/26), 87% (20/23), and 93%
28/30), respectively, of the Salmonella spp. strains were mul-
idrug resistant. The highest numbers of ESBL-positive strain
ere isolated from Room 4, corresponding to 54% (24/44) ofhe positive strains.
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ig. 1 – Resistance proﬁle of multidrug resistant Salmonella
pp. strains as per ESBL analysis and cutting room of
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Discussion
Recently, incidence of antimicrobial resistance in Salmonella
spp. isolated from foods of animal origin, especially poultry
products, has increased.27–29 In this study, all strains were
sensitive to ciproﬂoxacin and 95% of them were resistant to
nalidixic acid (Fig. 2). Hamidiam et al.30 suggested that the
low in vitro resistance to ciproﬂoxacin may be due to a muta-
tion in the gyrA gene and that in vitro resistance to nalidixic
acid may be used to detect the actual level of resistance to
ciproﬂoxacin. The CLSI22 recommends that resistance to this
class of antimicrobials should be considered as collective, that
is, resistance to one drug implies that the microorganism is
resistant to the whole class. This information is of great impor-
tance because ﬂuoroquinolones are considered as the drug of
ﬁrst choice for the treatment of infections caused by Salmonella
spp. in human.31
High levels of resistance were also observed against tetra-
cycline (Fig. 2). Worldwide incidence of resistance in Salmonella
spp. isolated from the poultry production chain is vari-
able with percentages ranging from 96.6% to 21.8%.32–34 In
Brazil, Oliveira et al.35 reported low resistance indexes in
Salmonella Enteritidis isolated from humans, poultry car-
casses, poultry-related samples, and food items involved in
food borne disease outbreaks in the southern region of the
country.
Additionally, 97% of the strains tested were sensitive to
chloramphenicol (Fig. 2), which is one of the ﬁrst drugs used
in veterinary medicine and which has been banned from ani-
mal  production in Brazil since 1998.36 The use of tetracycline
as a growth promoter in poultry production is also prohibited
in Brazil.37
All strains were sensitive to the carbapenems tested;
this is an important ﬁnding because carbapenems are the
drugs of ﬁrst choice in the treatment of ESBL-producing
microorganisms.38 ESBL production was detected in 45%
(44/98) of the strains. These ESBL-positive strains were also
multidrug resistant. Clemente et al.17 analyzed 1120 iso-
lates of Salmonella spp. from food items of animal origin
and found only ﬁve ESBL-producing strains. However, they
used a methodology that was different from the present one.
Nogueira-Miranda et al.10 compared six methodologies for the
detection of ESBL in Enterobacter spp. and concluded that the
double disk diffusion test showed sensitivity of 89.2% and
speciﬁcity of 100% for this species. Due to the absence of a
standard methodology approved by any of the international
committees for the evaluation of Salmonella spp., ESBL produc-
tion may result in underestimation of the occurrence of this
phenotype. It is also difﬁcult to compare different studies. The
phenotypic conﬁrmatory tests are highly sensitive and spe-
ciﬁc as compared to the genotypic conﬁrmatory tests.39 This
study was aimed to screen ESBL producing organisms. Fur-
ther research is required for the genotypic characterization
of ESBL-producing Salmonella spp. found in broiler processing
plants.
In conclusion, the present study demonstrated multidrug
resistance in 86% and ESBL activity in 45% of the Salmonella
spp. isolated from the studied broiler processing plants. These
results should be taken as a precautionary warning for the
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Fig. 2 – Percentages recorded for the antimicrobial susceptibility test of Salmonella spp. strains isolated from cutting rooms
of broiler processing plants. AMP,  ampicillin; CFC, cephachlor; CTF, ceftiofur; MER, meropenem; IPM, imipenem; EST,
streptomycin; TOB, tobramycin; GEN, gentamycin; AMI, amikacin; NEO, neomycin; ENO, enroﬂoxacin; NAL, nalidixic acid;
CIP, ciproﬂoxacin; SUT, sulfamethoxazole/trimethoprim; TET, tetracycline; CLO, chloramphenicol; FLF, ﬂorfenicol; POL,
rpolymyxin B.
spread of multidrug resistant Salmonella spp. in broiler pro-
duction industry.
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